225 related articles for article (PubMed ID: 11859)
41. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
42. Treatment of aplastic anemia.
Loughran TP; Storb R
Hematol Oncol Clin North Am; 1990 Jun; 4(3):559-75. PubMed ID: 2193014
[TBL] [Abstract][Full Text] [Related]
43. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
Locatelli F; Bruno B; Zecca M; Van-Lint MT; McCann S; Arcese W; Dallorso S; Di Bartolomeo P; Fagioli F; Locasciulli A; Lawler M; Bacigalupo A
Blood; 2000 Sep; 96(5):1690-7. PubMed ID: 10961865
[TBL] [Abstract][Full Text] [Related]
44. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
[TBL] [Abstract][Full Text] [Related]
45. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H
Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
[TBL] [Abstract][Full Text] [Related]
46. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia.
Storb R; Thomas ED; Buckner CD; Clift RA; Deeg HJ; Fefer A; Goodell BW; Sale GE; Sanders JE; Singer J; Stewart P; Weiden PL
Ann Intern Med; 1980 Jan; 92(1):30-6. PubMed ID: 6985782
[TBL] [Abstract][Full Text] [Related]
47. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332
[TBL] [Abstract][Full Text] [Related]
48. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia.
Dufour C; Dallorso S; Casarino L; Corcione A; Pistoia V; Bacigalupo A; Morreale G; Dini G
Bone Marrow Transplant; 1999 Apr; 23(7):743-5. PubMed ID: 10218856
[TBL] [Abstract][Full Text] [Related]
49. Marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Kawahara K; Witherspoon RP; Storb R
Am J Hematol; 1992 Apr; 39(4):283-8. PubMed ID: 1553957
[TBL] [Abstract][Full Text] [Related]
50. Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine.
Takpradit C; Prockop SE; Kernan NA; Scaradavou A; Curran K; Ruggiero J; Zakak N; O'Reilly RJ; Boulad F
J Pediatr Hematol Oncol; 2018 May; 40(4):e220-e224. PubMed ID: 29432302
[TBL] [Abstract][Full Text] [Related]
51. [Bone marrow transplantation in leukemia and aplastic anemia].
Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483
[TBL] [Abstract][Full Text] [Related]
52. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
[TBL] [Abstract][Full Text] [Related]
53. Bone marrow transplantation in 65 patients with severe aplastic anemia.
Gluckman E; Devergie A; Gerotta I; Hors J; Sasportes M; Boiron M; Bernard J
Bull Cancer; 1981; 68(1):74-7. PubMed ID: 7013871
[TBL] [Abstract][Full Text] [Related]
54. Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe aplastic anemia.
Giebel S; Wojnar J; Krawczyk-Kulis M; Markiewicz M; Wylezoł I; Seweryn M; Holowiecka-Goral A; Holowiecki J
Ann Transplant; 2006; 11(2):23-7; discussion 32-43. PubMed ID: 17494286
[TBL] [Abstract][Full Text] [Related]
55. [Second allogenic bone marrow transplantation after late graft rejection in a patient with severe aplastic anemia].
Stamatović D; Balint B; Todorić-Zivanović B; Marjanović S; Lakić-Trajković Z; Malesević M
Vojnosanit Pregl; 2000; 57(5):95-8. PubMed ID: 11213682
[TBL] [Abstract][Full Text] [Related]
56. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Stucki A; Leisenring W; Sandmaier BM; Sanders J; Anasetti C; Storb R
Blood; 1998 Oct; 92(8):2742-9. PubMed ID: 9763558
[TBL] [Abstract][Full Text] [Related]
57. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
[TBL] [Abstract][Full Text] [Related]
58. Allogeneic transplantation using CD34
Purev E; Tian X; Aue G; Pantin J; Vo P; Shalabi R; Reger RN; Cook L; Ramos C; Cho E; Worthy T; Khuu H; Stroncek D; Young NS; Childs RW
Br J Haematol; 2017 Mar; 176(6):950-960. PubMed ID: 28169418
[TBL] [Abstract][Full Text] [Related]
59. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
Geller RB; Devine SM; O'Toole K; Persons L; Keller J; Mauer D; Holland HK; Dix SP; Piotti M; Redei I; Connaghan G; Heffner LT; Hillyer CD; Waller EK; Winton EF; Wingard JR
Bone Marrow Transplant; 1997 Aug; 20(3):219-25. PubMed ID: 9257890
[TBL] [Abstract][Full Text] [Related]
60. Retransplantation of human bone marrow. Two immunosuppressive drug regimens.
Kersey J; Roloff J; Hokeness S; Johnson FL; Nesbit M; Krivit W
Transplantation; 1975 Jun; 19(6):475-8. PubMed ID: 237352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
